S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

TXG 10x Genomics Inc

10.40

-0.19 (-1.79%)

Last Updated: 04:40:17

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

02/28/2025

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

09/12/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Serge Saxonov

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more 10x Genomics Charts.

10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more 10x Genomics Charts.

10x Genomics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (7 days ago) • Edgar (US Regulatory)

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products
Tuesday 4 March 2025 (1 week ago) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Saturday 1 March 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 27 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 27 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 25 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 25 February 2025 (2 weeks ago) • Edgar (US Regulatory)

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
Monday 24 February 2025 (2 weeks ago) • PR Newswire (US)

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
Wednesday 19 February 2025 (3 weeks ago) • PR Newswire (US)

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 14 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 13 February 2025 (4 weeks ago) • Edgar (US Regulatory)

10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025
Thursday 13 February 2025 (4 weeks ago) • PR Newswire (US)

More 10x Genomics Inc News Articles

JP Morgan Chase

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions